OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness
Status:
Recruiting
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of OM-85 compared to placebo in reducing the
number of respiratory tract infections (RTIs) in children aged between 6 months and 5 years.